Busy day for the SCOTUS – good day for consumers

Today the United States Supreme Court ruled in a 5-3 vote that agreements between the companies that make name-brand and generic drugs to delay the generics’ availability can be illegal. Federal regulators can now sue drug companies for antitrust violations when those brand-name drug makers pay generic competitors to keep cheaper, rival copies of a drug off the market.… [Read more]